bioRxivMicrobiology
Heightened virulence of Yersinia is associated with decreased function of the YopJ protein
C. A. Mares, F. P. Lugo, M. Albataineh, B. Goins, I. Newton, R. R. Isberg, M. Bergman
Abstract
Despite the maintenance of YopP/J alleles throughout the human-pathogenic Yersinia lineage, the benefit of YopP/J-induced phagocyte death for Yersinia pathogenesis in animals is not obvious. To determine how sequence divergence of YopP/J has impacted Yersinia virulence, we examined protein polymorphisms in this Type III secreted effector protein across 17 Yersinia species, and tested the consequences of polymorphism in a murine model of sub-acute systemic yersiniosis. Our evolutionary analysis revealed that codon 177 has been subjected to positive selection - the Y. enterocolitica residue had been altered from a leucine to a phenylalanine in nearly all Y. pseudotuberculosis and Y. pestis strains examined. Despite being a minor change, as both leucine and phenylalanine have hydrophobic side chains, reversion of YopJF177 to the ancestral YopJL177 variant yielded a Y. pseudotuberculosis strain with enhanced cytotoxicity towards macrophages, consistent with previous findings. Surprisingly, expression of YopJF177L in the mildly attenuated ksgA- background rendered the strain completely avirulent in mice. Consistent with this hypothesis that YopJ activity indirectly relates to Yersinia pathogenesis in vivo, ksgA- strains lacking functional YopJ failed to kill macrophages but actually regained virulence in animals. Also, treatment with the anti-apoptosis drug suramin prevented YopJ-mediated macrophage cytotoxicity and enhanced Y. pseudotuberculosis virulence in vivo. Our results demonstrate that Yersinia-induced cell death is detrimental for bacterial pathogenesis in this animal model of illness, and indicate that positive selection has driven YopJ/P and Yersinia evolution towards diminished cytotoxicity and increased virulence, respectively.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Gain of Function Analysis Reveals Non-Redundant Roles for the Yersinia pestis Type III Secretion System Effectors YopJ, YopT, and YpkA
S. G. Palace, M. K. Proulx, … J. D. Goguen·bioRxiv·Apr 28, 2018
- A Yersinia effector activates JAK-STAT signaling in human macrophages
L. Berneking, I. Bekere, … M. Aepfelbacher·bioRxiv·May 8, 2023
- Immune activation of primary human macrophages is suppressed by the coordinated action of Yersinia effectors
Indra Bekere, Sören Rob, … Martin Aepfelbacher·mBioPeer-reviewed·Nov 24, 2025
- Yersinia Type III-Secreted Effectors Evade the Caspase-4 Inflammasome in Human Cells
J. Zhang, I. E. Brodsky, S. Shin·bioRxiv·Jan 24, 2023
- Inflammatory monocytes promote pyogranuloma formation to counteract Yersinia blockade of host defense
D. Sorobetea, R. Matsuda, … I. E. Brodsky·bioRxiv·Feb 6, 2022
- The Yersinia pestis virulence effector YopM binds the human pyrin death domain to inhibit inflammasome activation and effector-triggered immunity
Bethany W. Mwaura, Adam R. Simard, … James B. Bliska·bioRxiv·Jun 9, 2026